Newsletter

Charlie Youlden

Charlie is an Associate Equity Research Analyst covering ASX small caps across technology, mining and industrials.

His investing journey began in 2020 with large-cap US technology stocks, before he went on to complete a Commerce degree in Finance and Marketing at UTS, the Wall Street Prep Financial Modelling course, and Columbia Business School’s Value Investing course.

Charlie’s goal is to make investing clear, digestible and genuinely useful for everyday retail investors, helping them make better decisions with more confidence.

984 articles published

Financials Growth Stocks

Powerhouse Ventures (ASX:PVL) Builds a Merchant Revenue Engine as CIO Fund Scales

The New Revenue Engine Investors Are Starting to Notice Powerhouse Ventures (ASX:PVL) is now trading at A$0.15 per share. Since we began covering the stock two months ago and adopted a bullish stance at A$0.11, investors are now up around 25%. The Re-rate came as the company has made strong progress with its commercial pivot, combining…

ByCharlie Youlden19 hours ago0Comments

AI Stocks Healthcare Stocks Small Caps Stocks

Enlitic (ASX:ENL) locks in A$15m raise and finally clears the convertible note overhang

Enlitic (ASX:ENL) has secured a A$15m conditional placement and will convert its A$10m note stack, leaving A$18m pro forma cash and no debt.

ByCharlie Youlden20 hours ago0Comments

Cannabis Stocks Healthcare Stocks Small Caps Stocks

ECS Botanics (ASX:ECS) just got a German regulatory tailwind its rivals can’t easily match

ECS Botanics (ASX:ECS) says new Hesse GMP guidance in Germany may tighten compliant cannabis supply and favour its integrated OzSun platform.

ByCharlie Youlden20 hours ago0Comments

Copper Stocks Resources Small Caps Stocks

GreenTech Metals (ASX:GRE) locks in 8,300m drill program as copper takes over

GreenTech Metals (ASX:GRE) locks in an 8,300m Pilbara drill program and pivots Munni Munni toward a copper-PGE concentrate story.

ByCharlie Youlden20 hours ago0Comments

Biotech Stocks Healthcare Stocks Small Caps Stocks

Racura Oncology (ASX:RAC) unlocks two top-tier cancer centres for HARNESS-1 enrolment push

Racura Oncology (ASX:RAC) secures Bellberry ethics approval for HARNESS-1, activating Chris O’Brien Lifehouse and Austin Health for its EGFR lung cancer trial.

ByCharlie Youlden20 hours ago0Comments

Blue Chip Stocks Dividend Stocks Financials

Suncorp (ASX:SUN) holds upper-end margins through a A$250m hazard overrun

Suncorp Group (ASX:SUN) reaffirms upper-end FY26 ITR margins despite a A$250m nat hazard overrun as the FY27 reinsurance program is placed.

ByCharlie Youlden20 hours ago0Comments

Small Caps Stocks Tech Stocks

Motio (ASX:MXO) posts record June and Q1 FY27 forward bookings jump 20.3%

Motio (ASX:MXO) posted its highest-ever revenue month in June 2026 and Q1 FY27 forward bookings jumped 20.3% as operating leverage emerges.

ByCharlie Youlden21 hours ago0Comments

Gold Stocks Resources Small Caps Stocks

Mamba Exploration (ASX:M24) pegs 10km² of new ground as Meeka East drilling nears

Mamba Exploration (ASX:M24) expands Meeka East tenure by 10km² and sets a late-July heritage survey ahead of a 50-hole RC drill program.

ByCharlie Youlden21 hours ago0Comments

Healthcare Stocks Life Sciences Small Caps Stocks

OncoSil Medical (ASX:OSL) files FDA submission with a 45-day clock now ticking

OncoSil Medical (ASX:OSL) has filed its FDA Humanitarian Device Exemption submission for dCCA, with the agency signalling a 45-day review window.

ByCharlie Youlden21 hours ago0Comments

Gold Stocks Mid Cap Stocks Resources

Catalyst Metals (ASX:CYL) doubles Plutonic output to 104koz as 200koz target sharpens

Catalyst Metals (ASX:CYL) closed FY26 with 104koz of gold and A$323m cash. Trident underground is the next catalyst on the 200koz path.

ByCharlie Youlden21 hours ago0Comments

the Kick-ass Multipurpose WordPress Theme

Charlie Youlden

Powerhouse Ventures (ASX:PVL) Builds a Merchant Revenue Engine as CIO Fund Scales

Enlitic (ASX:ENL) locks in A$15m raise and finally clears the convertible note overhang

ECS Botanics (ASX:ECS) just got a German regulatory tailwind its rivals can’t easily match

GreenTech Metals (ASX:GRE) locks in 8,300m drill program as copper takes over

Racura Oncology (ASX:RAC) unlocks two top-tier cancer centres for HARNESS-1 enrolment push

Suncorp (ASX:SUN) holds upper-end margins through a A$250m hazard overrun

Motio (ASX:MXO) posts record June and Q1 FY27 forward bookings jump 20.3%

Mamba Exploration (ASX:M24) pegs 10km² of new ground as Meeka East drilling nears

OncoSil Medical (ASX:OSL) files FDA submission with a 45-day clock now ticking

Catalyst Metals (ASX:CYL) doubles Plutonic output to 104koz as 200koz target sharpens

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Charlie Youlden

Stocks in Spotlight

Add Your Heading Text Here